Making the Invisible Visible: New Insights and Implications for Clinical Practice in Axial Spondyloarthritis
With innovative approaches emerged, treatment goal of Axial Spondyloarthritis is evolving from clinical symptom relief to remission. This Novartis satellite symposium, “Making the Invisible Visible – New Insights and Implications for Clinical Practice in AxSpA” will be chaired by Prof. Chang-Youh Tsai and Prof. Der-Yuan Chen from Taiwan to address two challenging topics raised by the new treatment target:
Prof. Mikkel Østergaard, from Denmark, will share with the audience the latest discoveries as well as the future perspectives of the IL-17 inhibition, how this has affected the inflamation cascade, structure damage, further to patients’ mobility and how we can leverage this as a new approach to efficiently treat patients with Axial Spondyloarthritis.
Treatment goals of Axial Spondyloarthritis are now focused on clinical remission or achievement of low disease activity. To realize them with digital solutions, Dr. Hsin-Hua Chen, from Taiwan, would like to share a preliminary result of management outcome delivered by a center-specific digital monitor system. This systemic approach is to closely monitor the status of disease activity of individual patient with non-biologic or biologic treatment. While more therapeutic target, like IL-17A, being proved effectively to treat Axial Spondyloarthritis, this offers patients more options and the measurement result may be served as a guidance to formulate an individualized management strategy to achieve treatment goal.
Prof. Chang-Youh Tsai, Taipei Veteran General Hospital, Taiwan
Prof. Der-Yuan Chen, China Medical University Hospital, Taiwan
Prof. Mikkel Østergaard, University of Copenhagen, Denmark
Dr. Hsin-Hua Chen, Taichung Veterans General Hospital, Taiwan
|1300-1305||Opening Remarks||Prof. Chang-Youh Tsai|
|1305-1350||IL-17A Inhibition in Axial Spondyloarthritis: Current and Future Perspectives||Prof. Mikkel Østergaard||Prof. Chang-Youh Tsai|
|1350-1420||Can We Aim Higher to Treat Axial Spondyloarthritis?||Dr. Hsin-Hua Chen||Prof. Der-Yuan Chen|
|1420-1430||Panel Discussion and Closing Remarks||Prof. Der-Yuan Chen|